ABSTRACT-
a-Adrenoceptors have been subclassified pharmaco logically into 2 types: alpha I and 2 (1, 2). It has been also reported that the a,-adrenoceptor subtype linked to vasoconstriction is more predominant in vascular smooth muscle than the postsynaptic a2-adrenoceptor subtype (3, 4). Moreover, a,-adrenoceptors are not homogenous in various vasculatures and their heterogeneity has been sug gested to be related to the differences in vascular response. Recently, Muramatsu et al. (5 7) and Suzuki et al. (8) have demonstrated that a,-adrenoceptors of rab bit blood vessels can be classified into two or three sub types. In our laboratories, by using the cannula inserting method developed by Hongo and Chiba (9) and modified by Tsuji and Chiba (10), investigated the effects of al-adrenoceptor agonists in isolated dog, monkey and rat vasculatures. However, they did not in vestigate the effects in rabbit vascular beds. Moreover, it is well-recognized that the density of a-adrenoceptors dif feres from organ to organ, indicating the organ specificity of vessels (2-4). Thus, in the present study we used the cannula inserting method (9, 10), which is different from other methodologies, to examine the vascular effects of selective a, and a2-adrenoceptor agonists in the isolated, perfused rabbit common carotid, renal and femoral arter ies to clarify the pharmacological characteristics and regional differences of three vessels in the rabbit.
MATERIALS AND METHODS

Cannula inserting method
Male or female Japanese white rabbits weighing 2.0 to 2.5 kg were anesthetized with sodium pentobarbital (30 mg/kg, i.v.). After treatment with sodium heparin (200 units/kg, i.v.) , the animals were killed by rapid exsangui nation from the abdominal aorta. The common carotid, renal and femoral arteries were then carefully isolated, and small branches were ligated as much as possible. Each vessel was cannulated with a stainless steel cannula with one small side hole at 5-mm distance from the distal blind end (15 gauge in the common carotid artery and 20 gauge in other arteries, with a length of 4 cm). The com mon carotid artery was 3.0-4.0 cm, and the other arteries were 2.0-3.0 cm in length. Each cannulated vessel was placed in a cup-shaped glass container maintained at 371C. The perfusion pressure was readily elevated to 50-80 mmHg in the three kinds of arteries when the per fusion flow was increased. Thus, each vessel preparation was perfused with a constant flow rate (3.0-5.0 ml/min) by means of a micro-tube pump (Tokyo Rikakikai Co., Ltd., Tokyo). Under these conditions, the contractile responses to KCI of the three vessels were almost the same. Vasoconstriction or dilation was observed as an in crease or decrease in perfusion pressure, respectively. The perfusate contained: 118 mM NaCI, 4.7 mM KCI, 2.5 mM CaC12, 1.2 mM KH2PO4, 1.2 mM MgSO4, 25 mM NaHCO3 and 10 mM glucose; and it was bubbled with 95% 02 and 5% CO2. The perfusion pressure was continu ously measured with an electric manometer (Nihon Koh den TP-200P, Tokyo). The details and advantages of the cannula inserting method were described in previous papers (9, 10).
Drugs
Drugs used in this study were phenylephrine hydrochlo ride (PE; Kowa, Tokyo), methoxamine hydrochloride (ME; Nippon Shinyaku, Tokyo), clonidine hydrochloride (CL; Boehringer Ingelheim, F.R.G.), xylazine hydrochlo ride (XY; Bayer A.G., F.R.G.), bunazosin hydrochloride
(PGF2a; Ono, Osaka) and 5-hydroxytryptamine creati nine sulfate (5-HT; Merck, F.R.G.). The drug solution (dose in terms of mol) was bolusly injected intraluminally into the isolated vessel from the rubber tube close to the cannula in a volume of 0.01-0.03 ml for a period of 4 sec. To induce preconstrictions, 10-5 M PE or 3 x 10-6 M PGF2a, dissolved in perfusate, was continuously infused to produce a stable long-lasting vasoconstriction. Bunazo sin, a selective a,-antagonist or midaglizole, a selective a2 antagonist, was administered bolusly before each injec tion of a-agonists in preconstricted or nonpreconstricted vessels.
Statistical analyses
The results are expressed as the mean ±S.E.M. Statisti cal differences between two means and two curves were de termined by Student's t-test for unpaired observations and analyses of variance, respectively. 
RESULTS
Effects of a-adrenoceptor agonists on rabbit common carotid, renal and femoral arteries When PE and ME, selective a,-agonists, were admin istered to an isolated arterial preparation, a vasoconstric tion was induced in a dose-dependent manner. The threshold dose for inducing a constriction was approxi mately of 10-12 mol; an increase in perfusion pressure of more than 100 mmHg was usually observed at a dose of 10-8 mol. Table 1 shows the EC50 values in three different kinds of vessels, and these a,-agonists induced a stronger vasoconstriction in the femoral arteries than in the other arteries. The selective a2-agonist XY did not cause any constriction on renal and femoral arteries, but it produced only a slight vasoconstrictory response of the common carotid artery at 10-8 mol. Another relatively selective a2-agonist, CL, induced a dose-dependent in crease in perfusion pressure of the common carotid artery over 80 mmHg at 10-8 mol, but CL produced had little effect on renal and femoral arteries. Figure 1 shows the summarized data of the dose-response curves for 4 differ ent a-agonists.
Effects of bunazosin on a,-adrenoceptor-induced vasocon strictions When bunazosin, a selective a,-adrenoceptor an tagonist (15), was given into the perfusion line at a dose of 2.7 x 10-8 mol, the perfusion pressure did not change significantly. After pretreatment with bunazosin, vaso constrictive actions of PE, ME and CL were markedly in hibited. As shown in Fig. 2 , bunazosin caused a shift of the dose-response curve for PE to the right in a parallel fashion in three vessels. Although we did not show the figure, the dose-response curve for ME was also shifted by bunazosin treatment in the same fashion. Moreover, bunazosin readily inhibited the CL-induced vasoconstric tions in the common carotid artery, as shown in Fig. 3 . On the other hand, these responses were not changed af ter treatment with 1.2 x 10-' mol midaglizol, a selective a2-antagonist (data not shown). Because the antagonist was bolusly injected in this method, we could not show the exact pA2 values. Since XY did not produce a consis tent vasoconstriction, we did not perform the same experi ments with bunazosin and midaglizol. Effects of a2-adrenoceptor agonists on preconstricted ves sels induced by PE When a relatively large concentration of PE, 10-5 M, was continuously perfused in the three kinds of arteries, a longlasting vasoconstriction was readily obtained as reported previously (16). In this condition, PE induced almost the same increases of 104:L12, l07±8 and 102± 18 mmHg in perfusion pressure in the common carotid, renal and femoral arteries, respectively. During a long-lasting vasoconstriction by PE, vascular responses to CL and XY were investigated in the three kinds of ar teries. Each a2-adrenoceptor agonist induced a clear vaso dilation in a dose-related manner, causing decreases in perfusion pressure for 5 to 11 min in a dose range of 10-' 1 -10-8 mol . The vasodilatory effects were calculated as % changes of the preconstricted pressure. None of the vasodilatory effects were changed after treatment with 1.2 x 10-7 mol midaglizole, a selective a2-blocker (17). Summarized data are shown in Fig. 4 . Effects of a2-adrenoceptor agonists on preconstricted preparations produced by an infusion of PGF2a During a continuous infusion of 10-'M PGF2a, a sta ble vasoconstriction was readily obtained. The pressure rose to 40± 12 mmHg; this rise was almost equal in the three vessels. XY did not induce any change in perfusion pressure when the vessel was preconstricted by PGF2a (da ta not shown). CL also induced neither vasodilation nor vasoconstriction in renal and femoral arteries, but instead produced a weak vasoconstriction in a dose-dependent manner in the common carotid arteries. The vasoconstric tions induced by 10-13-10-8 mol of CL were completely inhibited by 2.7 x 10-8 mol bunazosin in the common carotid arteries (Fig. SA) . Moreover, during a continuous infusion of 10-6 M 5-HT, during which the pressure was from 80 to 100 mmHg in each artery, CL and XY induced the same responses as those in PGF2a-preconstricted ves sels.
DISCUSSION
The pharmacological heterogeneity of vasoconstrictor responses to various sympathomimetic agents has been generally accepted, indicating the subdivision of vascular a-adrenoceptors mediating a vasoconstriction into gl and a2-adrenoceptors (18) (19) (20) . Recently, the al adrenoceptors of blood vessels have been classified into two or three subtypes (6-9). There have been many stu dies on the vasoconstrictive properties of a1-adrenoceptor agonists, but there is little literature available to prove the existence of functional post-junctional a2-adrenoceptors in isolated rabbit arterial preparations. Docherty et al.
(21) reported that post-junctional al-adrenoceptors were abundant in the rabbit aorta, but functionally there was no evidence for the presence of a2-adrenoceptors. Schumann and Lues (22) demonstrated that the rabbit saphenous vein has no apparent a2-adrenoceptors in vitro, but the presence of angiotensin reveals these a2 receptors.
In the present study, we functionally examined the dis tribution of al and a2-adrenoceptors in the rabbit com mon carotid, renal and femoral arteries by the cannula in serting method (10, 11) to evaluate the regional and spe cies differences of a-adrenoceptors. PE and ME showed almost the same potency for inducing vasoconstrictive responses and the same threshold dose in the three kinds of arteries. However, these agents induced a stronger vasoconstriction in the femoral arteries than in the com mon carotid and renal arteries. As PE and ME-induced vasoconstrictions were readily suppressed by al adrenoceptor blockade, these responses might be due to an activation of al-adrenoceptors.
On the other hand, CL produced a relatively small vasoconstriction only in the common carotid artery which was readily suppressed by bunazosin but not by midagli zole. As CL has al-adrenoceptor stimulating properties (17), the CL-induced vasoconstriction might be due to an activation of al but not a2-adrenoceptors. Although sev eral authors reported that CL caused a constriction of rab bit renal and femoral arteries (23 25), in this study, CL produced only a faint response in the renal and femoral ar teries. In our laboratories, Chiba and Tsukada (11) also reported that the canine mesenteric artery showed no response to CL and XY in spite of the existence of dominant al-adrenoceptors, contradicting the results by Shepperson et al. (26) . One possible reason for the dis crepancy may be that one is due to regional intraluminal perfusion preparations but they used spiral vessel prepara tions or in vivo studies, and an other possibility is that CL has different properties as an al-agonist compared with other al-agonists under an intraluminal bolus injection. In other words, CL-sensitive receptors may exist. Although we could not show what subtypes of al adrenoceptors CL activates, this property may cause dif ferent vascular responses in these three vessels. XY in duced no significant influence in any of the non-treated ar teries.
Moreover, the a2-adrenoceptor agonist-induced vasodi lations were not inhibited by a potent a2-adrenoceptor an tagonist, midaglizole, in the preparations preconstricted by phenylephrine. Therefore, the present data indicate that these responses are not mediated via an activation of a2-adrenoceptors.
Thus, it is considered that there are abundant al-adrenoceptors, but few functional a2 adrenoceptors existing in rabbit peripheral arteries.
Among the three different vessel preparations, femoral arteries showed relatively larger dilatory and constrictor responses than the other arteries, suggesting that femoral arteries, which mainly perfuse skeletal muscle.
In preparations pre-constricted by PGF2a, neither XY nor CL induced any vasodilation, but they instead produced vasoconstrictions only in the common carotid arteries which could be suppressed by bunazosin. This also indicates that CL is a partial al-adrenoceptor agonist, but XY is not. Agrawal and Daniel (27) reported that a2-adrenoceptor agonists exhibited their antagonistic activity at al adrenoceptors in ring preparations of rat mesenteric ar teries preconstricted by al-adrenoceptor agonists. Kong et al. (28) also showed that CL antagonized the vasocon strictor effect of NE in cannulated rat mesenteric arteries with the intestine attached. They explained that this mechanism of CL might be due to interference with al adrenoceptor-mediated contraction. This antagonistic ac tion might be at the level of the receptor site but they could not clarify the post-receptor steps.
In our laboratories, Chiba and Tsukada (16) also demonstrated that four kinds of a2 adrenoceptor agonists showed distinct antagonistic action towards al-adrenocep tor-mediated effects in rat common carotid arteries by use of the cannula inserting method.
a2-Adrenoceptor agonists have been reported to behave as an antagonist at al-adrenoceptors in the rabbit aorta (29) . In this study, we used PE as an al-adrenoceptor agonist, which was more selective than NE, and CL and XY as a2-agonists. 
